Annual Accounts Payable
$2.11 M
-$1.04 M-33.06%
December 31, 2023
Summary
- As of February 8, 2025, IMRX annual accounts payable is $2.11 million, with the most recent change of -$1.04 million (-33.06%) on December 31, 2023.
- During the last 3 years, IMRX annual accounts payable has risen by +$631.20 thousand (+42.63%).
- IMRX annual accounts payable is now -33.06% below its all-time high of $3.15 million, reached on December 31, 2022.
Performance
IMRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.94 M
-$679.40 K-25.91%
September 30, 2024
Summary
- As of February 8, 2025, IMRX quarterly accounts payable is $1.94 million, with the most recent change of -$679.40 thousand (-25.91%) on September 30, 2024.
- Over the past year, IMRX quarterly accounts payable has dropped by -$328.10 thousand (-14.45%).
- IMRX quarterly accounts payable is now -38.41% below its all-time high of $3.15 million, reached on December 31, 2022.
Performance
IMRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IMRX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.1% | -14.4% |
| 3 y3 years | +42.6% | -38.4% |
| 5 y5 years | +616.1% | -38.4% |
IMRX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.1% | +51.5% | -38.4% | +56.6% |
| 5 y | 5-year | -33.1% | +616.1% | -38.4% | +56.6% |
| alltime | all time | -33.1% | +616.1% | -38.4% | +56.6% |
Immuneering Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.94 M(-25.9%) |
| Jun 2024 | - | $2.62 M(+15.5%) |
| Mar 2024 | - | $2.27 M(+7.5%) |
| Dec 2023 | $2.11 M(-33.1%) | $2.11 M(+8.8%) |
| Sep 2023 | - | $1.94 M(-27.9%) |
| Jun 2023 | - | $2.69 M(-1.1%) |
| Mar 2023 | - | $2.72 M(-13.7%) |
| Dec 2022 | $3.15 M | $3.15 M(+34.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $2.34 M(+88.6%) |
| Jun 2022 | - | $1.24 M(-24.5%) |
| Mar 2022 | - | $1.64 M(+17.8%) |
| Dec 2021 | $1.39 M(-5.8%) | $1.39 M(-22.3%) |
| Sep 2021 | - | $1.80 M(+25.3%) |
| Jun 2021 | - | $1.43 M(+4.7%) |
| Mar 2021 | - | $1.37 M(-7.5%) |
| Dec 2020 | $1.48 M(+402.0%) | $1.48 M |
| Dec 2019 | $294.90 K | - |
FAQ
- What is Immuneering annual accounts payable?
- What is the all time high annual accounts payable for Immuneering?
- What is Immuneering annual accounts payable year-on-year change?
- What is Immuneering quarterly accounts payable?
- What is the all time high quarterly accounts payable for Immuneering?
- What is Immuneering quarterly accounts payable year-on-year change?
What is Immuneering annual accounts payable?
The current annual accounts payable of IMRX is $2.11 M
What is the all time high annual accounts payable for Immuneering?
Immuneering all-time high annual accounts payable is $3.15 M
What is Immuneering annual accounts payable year-on-year change?
Over the past year, IMRX annual accounts payable has changed by -$1.04 M (-33.06%)
What is Immuneering quarterly accounts payable?
The current quarterly accounts payable of IMRX is $1.94 M
What is the all time high quarterly accounts payable for Immuneering?
Immuneering all-time high quarterly accounts payable is $3.15 M
What is Immuneering quarterly accounts payable year-on-year change?
Over the past year, IMRX quarterly accounts payable has changed by -$328.10 K (-14.45%)